FDA Warning Letter — Jiangsu NHWA Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Jiangsu NHWA Pharmaceutical Co., Ltd. on September 10, 2019 (Xuzhou, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Jiangsu NHWA Pharmaceutical Co., Ltd.
- Date
- September 10, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Xuzhou (China)